Neurogene Ownership | Who Owns Neurogene?

Neurogene Ownership Summary

Neurogene is owned by 76.94% institutional investors, 6.98% insiders, and 16.09% retail investors. Samsara biocapital is the largest institutional shareholder, holding 11.09% of NGNE shares. Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund, with 3.29% of its assets in Neurogene shares.

NGNE Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Neurogene	76.94%	6.98%	16.09%
Sector	Healthcare Stocks	244.37%	12.11%	-156.48%
Industry	Biotech Stocks	379.01%	11.75%	-290.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Samsara biocapital	1.72M	11.09%	$34.62M
Redmile group	1.46M	9.42%	$29.43M
Casdin capital	1.42M	9.17%	$28.63M
Rtw investments, lp	1.36M	8.80%	$27.47M
Ecor1 capital	1.27M	8.21%	$25.63M
Blackrock funding, inc. /de	1.01M	6.49%	$20.26M
Baker bros. advisors lp	991.69K	6.40%	$19.99M
Balyasny asset management	718.39K	4.64%	$14.48M
Toronto dominion bank	681.34K	4.40%	$13.74M
Jennison associates	527.68K	3.41%	$10.64M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Samsara biocapital	1.72M	3.36%	$34.62M
Great point partners	500.00K	2.32%	$10.08M
Casdin capital	1.42M	2.17%	$28.63M
Redmile group	1.46M	1.95%	$29.43M
Ecor1 capital	1.27M	1.09%	$25.63M
Octagon capital advisors lp	252.00K	0.66%	$4.37M
Arrowmark colorado	524.80K	0.28%	$10.58M
Rtw investments, lp	1.36M	0.27%	$27.47M
Dafna capital management	56.63K	0.26%	$1.14M
Rock springs capital management lp	104.34K	0.12%	$2.10M

Top Buyers

Holder	Shares	% Assets	Change
Fmr	382.65K	0.00%	252.32K
Great point partners	500.00K	2.32%	150.00K
Millennium management	204.81K	0.00%	133.49K
Casdin capital	1.42M	2.17%	125.00K
Balyasny asset management	718.39K	0.02%	109.81K

Top Sellers

Holder	Shares	% Assets	Change
Deerfield management company, l.p. (series c)	-	-	-446.88K
Commodore capital lp	-	-	-427.87K
Logos global management lp	-	-	-195.00K
Price t rowe associates inc /md/	-	-	-123.29K
Deep track capital, lp	-	-	-116.66K

New Positions

Holder	Shares	% Assets	Change	Value
Vanguard fiduciary trust	69.71K	0.00%	69.71K	$1.41M
Quadrature capital	16.83K	0.00%	16.83K	$291.97K
Mariner	16.69K	0.00%	16.69K	$336.41K
Aqr capital management	10.31K	0.00%	10.31K	$207.87K
Point72 asset management	7.67K	0.00%	7.67K	$132.91K

Sold Out

Holder	Change
Twin peaks wealth advisors	-5.00
Raymond james financial	-8.00
Corecap advisors	-11.00
Mai capital management	-11.00
Coldstream capital management	-20.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	117	15.84%	17,351,095	2.25%	76	1.33%	63	-	31	82.35%
Mar 31, 2026	97	3.19%	16,958,112	2.74%	109	1.80%	62	63.16%	15	-50.00%
Dec 31, 2025	17	-80.90%	1,452,749	-90.50%	6	0.13%	7	-83.33%	8	-68.00%
Sep 30, 2025	26	-67.50%	1,140,405	-92.30%	5	0.11%	13	-64.86%	7	-74.07%
Jun 30, 2025	83	-3.49%	15,385,506	2.02%	73	1.42%	39	-11.36%	27	17.39%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard MStar Total Stk Mkt Idx Invest	520.96K	3.29%	123.17K
Franklin Biotechnology Discv A(acc)USD	409.49K	2.59%	281.02K
Vanguard Total Stock Mkt Idx Inv	397.79K	2.51%	15.60K
Vanguard Morn Total Stk Mkt Idx Investor	397.79K	1.99%	15.60K
iShares Russell 2000 ETF	289.84K	1.45%	-5.18K
Franklin Biotechnology Discovery A	218.78K	1.38%	145.36K
Vanguard Institutional Extnd Mkt Idx Tr	126.98K	0.80%	303.00
PGIM Jennison Health Sciences Z	126.19K	0.80%	126.19K
Fidelity Advisor Biotechnology I	140.60K	0.70%	-65.77K
Stt Strt®SPDR®S&PKenshoNwEcosComposETF	100.70K	0.64%	-375.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jul 07, 2026	Cvijic Christine Mikail	President and CFO	Sell	$151.76K
Jul 06, 2026	Cvijic Christine Mikail	President and CFO	Sell	$21.61K
Jul 01, 2026	Cvijic Christine Mikail	President and CFO	Sell	$25.17K
Jul 02, 2026	Cvijic Christine Mikail	President and CFO	Sell	$87.52K
Jul 02, 2026	Cvijic Christine Mikail	President and CFO	Sell	$53.90K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	5
2026 Q2	-	2
2026 Q1	-	10
2025 Q2	-	1
2025 Q1	-	1

NGNE Ownership FAQ

Who Owns Neurogene?

Neurogene shareholders are primarily institutional investors at 76.94%, followed by 6.98% insiders and 16.08% retail investors. The average institutional ownership in Neurogene's industry, Biotech Stocks , is 379.01%, which Neurogene falls below.

Who owns the most shares of Neurogene?

Neurogene’s largest shareholders are Samsara biocapital (1.72M shares, 11.09%), Redmile group (1.46M shares, 9.42%), and Casdin capital (1.42M shares, 9.17%). Together, they hold 29.68% of Neurogene’s total shares outstanding.

Does Blackrock own Neurogene?

BlackRock is not among the top 10 institutional shareholders of Neurogene.

Who is Neurogene’s biggest shareholder by percentage of total assets invested?

Samsara biocapital is Neurogene’s biggest shareholder by percentage of total assets invested, with 3.36% of its assets in 1.72M Neurogene shares, valued at 34.62M$.

Who is the top mutual fund holder of Neurogene shares?

Vanguard MStar Total Stk Mkt Idx Invest is the top mutual fund holder of Neurogene shares, with 3.29% of its total shares outstanding invested in 520.96K Neurogene shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools